RxDoctor Payments Data

Kamran Abolmaali, MD

Plastic and Reconstructive Surgery · Huntington, WVNPI 1538489893

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 94.9% of the total across 87 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 23.0% — the pattern of someone who eats at a lot of different presentations.

$2,946in general payments, 2019–2025

Across 87 payments — averaging $33.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$676
  • Organogenesis Inc.$268
  • Medline Industries LP$266
  • Mentor Worldwide LLC$248
  • Galderma Laboratories, L.p.$213
  • Smith+Nephew$184
  • plus $1K from 19 others

What the payments were for

  • Speaking & faculty fees$1505%
  • Food & beverage$2,79695%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few plastic and reconstructive surgery providers in West Virginiato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$43,968
Medicare patients
34
Services billed
169

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen15$75
Cefadroxil16$69
Ondansetron Hcl12$35

Paid to pharmacies, not to this prescriber.

Other plastic and reconstructive surgery in Huntington

See the full list for West Virginia

Where these figures come from

Is this you, or does something look wrong? →